|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 235/06 | (2006.01) |
| A61K 31/4184 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3702351 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19211405.6 |
| Date of filing the European patent application | 2013-10-18 | |
| (97) | Date of publication of the European application | 2020-09-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-22 |
| (46) | Date of publication of the claims translation | 2024-01-10 |
| (30) | Number | Date | Country code |
| 201261716169 P | 2012-10-19 | US |
| (72) |
KRELL, Christoph, Max , CH
MISUN, Marian , DE
NIEDERER, Daniel, Andreas , CH
PACHINGER, Werner, Heinz , CH
WOLF, Marie-Christine , FR
ZIMMERMANN, Daniel , CH
LIU, Weidong , US
STENGEL, Peter, J. , US
NICHOLS, Paul , US
|
| (73) |
Array Biopharma, Inc. ,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos, apimančios MEK inhibitorių |
| FORMULATION COMPRISING A MEK INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-09-13 | 12 | 289.00 EUR |
| 2025-10-18 |